At the end of Q1 2026, 24 institutions reported holding Aeon Biopharma Inc. (AEON) in their 13F filings, up 2 from Q4 2025. 6 opened new positions and 5 sold out. The largest holders were Dauntless Investment Group, LLC ($2.5M), Vanguard Capital Management LLC ($89K) and Geode Capital Management, LLC ($86K).
Company
Aeon Biopharma Inc.
CUSIP
00791X209
Latest filing quarter
Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
Institutions
Total Value
New Positions
6
$51K
Exits
5
$46K
All 13F filers, Q4 2025 → Q1 2026: 473,101 shares bought and 79,678 shares sold, net +393,423 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.